2011 - Fellow of the American Association for the Advancement of Science (AAAS)
Member of the Association of American Physicians
Michael M. Lederman spends much of his time researching Immunology, Acquired immunodeficiency syndrome, Internal medicine, Immune system and Immunopathology. Immunology connects with themes related to Virology in his study. His biological study spans a wide range of topics, including Clinical trial and Cohort study.
Chemotherapy, Thrombocytopenic purpura and Chronic idiopathic thrombocytopenic purpura is closely connected to Gastroenterology in his research, which is encompassed under the umbrella topic of Internal medicine. The Immune system study combines topics in areas such as HEK 293 cells, Lipopolysaccharide and Disease. His Immunopathology research includes themes of Lymphocyte proliferation, Antibody, Immunization, Antigen and Virus.
The scientist’s investigation covers issues in Immunology, Virology, Internal medicine, Acquired immunodeficiency syndrome and Immune system. His work in Immunology addresses subjects such as Cytotoxic T cell, which are connected to disciplines such as Molecular biology. His Internal medicine study incorporates themes from Gastroenterology, Endocrinology, Surgery and Oncology.
His study in Acquired immunodeficiency syndrome is interdisciplinary in nature, drawing from both Viral disease, Clinical trial and Disease. He has researched Immune system in several fields, including Interleukin, Cytokine, Lymphocyte and Antigen. His studies deal with areas such as Inflammation and CD38 as well as CD8.
His primary areas of study are Immunology, Inflammation, Internal medicine, T cell and Immune system. His research integrates issues of Cytotoxic T cell and Virology in his study of Immunology. The various areas that Michael M. Lederman examines in his Inflammation study include Fibrosis, Pathogenesis and Lymph.
His study on Internal medicine also encompasses disciplines like
His main research concerns Immunology, Inflammation, Internal medicine, CD8 and Immune system. His studies in Immunology integrate themes in fields like Cytotoxic T cell and Antiretroviral therapy. His Internal medicine research integrates issues from Gastroenterology, Acquired immunodeficiency syndrome and Oncology.
The concepts of his Acquired immunodeficiency syndrome study are interwoven with issues in Malignancy, Logistic regression, Viremia, Circulating MicroRNA and Peripheral blood mononuclear cell. His work in CD8 addresses issues such as T cell, which are connected to fields such as microRNA, Case-control study, TFAM and Cell cycle. His Immune system research includes themes of Virology, Interleukin, Flow cytometry and Mitochondrion, Mitochondrial biogenesis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study
Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka.
PLOS ONE (2015)
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
Jason M. Brenchley;David A. Price;Timothy W. Schacker;Tedi E. Asher.
Nature Medicine (2006)
HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T-cells
Michael R. Betts;Martha C. Nason;Sadie M. West;Stephen C. De Rosa.
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation
Pereyra F;Jia X;McLaren Pj.
A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter
Scott M. Hammer;David A. Katzenstein;Michael D. Hughes;Holly Gundacker.
The New England Journal of Medicine (1996)
A Prospective Study of Human Immunodeficiency Virus Type 1 Infection and the Development of AIDS in Subjects with Hemophilia
James J. Goedert;Craig M. Kessler;Louis M. Aledort;Robert J. Biggar.
The New England Journal of Medicine (1989)
Plasma Levels of Bacterial DNA Correlate with Immune Activation and the Magnitude of Immune Restoration in Persons with Antiretroviral-Treated HIV Infection
Wei Jiang;Michael M. Lederman;Peter Hunt;Scott F. Sieg.
The Journal of Infectious Diseases (2009)
Immunologic Responses Associated with 12 Weeks of Combination Antiretroviral Therapy Consisting of Zidovudine, Lamivudine, and Ritonavir: Results of AIDS Clinical Trials Group Protocol 315
Michael Marcel Lederman;Elizabeth Connick;Alan Landay;Daniel R. Kuritzkes.
The Journal of Infectious Diseases (1998)
Dysbiosis of the Gut Microbiota Is Associated with HIV Disease Progression and Tryptophan Catabolism
Ivan Vujkovic-Cvijin;Richard M. Dunham;Shoko Iwai;Michael C. Maher.
Science Translational Medicine (2013)
HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality.
Sergio Serrano-Villar;Talia Sainz;Sulggi A. Lee;Peter W. Hunt.
PLOS Pathogens (2014)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: